Reduction of Hepatic Steatosis, Oxidative Stress, Inflammation, Ballooning and Insulin Resistance After Therapy with Safranal in NAFLD Animal Model: A New Approach.

J Inflamm Res · 2022 · PMC8886028 · PMID 35241921

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Furthermore, safranal treatment has shown a notable effect (p˂0.05) on uric acid levels with an increasing trend of protection (20.27%) at the dose of 500 mg/kg.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.